- Home
- BTBD vs BDRX Comparison
BTBD vs BDRX Comparison
Compare BTBD & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTBD | BDRX |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United Kingdom |
| Employees | 188 | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 2.5M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BTBD | BDRX |
|---|---|---|
| Price | $1.22 | $3.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 126.3K | ★ 190.2K |
| Earning Date | 05-15-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.60 |
| 52 Week High | $5.59 | $11.88 |
Technical Indicators
Market Signals| Indicator | BTBD | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 54.54 |
| Support Level | $1.15 | $2.97 |
| Resistance Level | $1.70 | $4.39 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 86.73 | 70.15 |
Price Performance
Historical ComparisonAbout BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.